Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer's Dementia Are Frequently Below the Recommended Levels
BackgroundAcetylcholinesterase inhibitors (AChE-I) are recommended for the treatment of cognitive symptoms but also of behavioral and psychological symptoms in dementia. They are widely used not only in Alzheimer's disease, but also in other forms of dementia. Efficacy of treatment might depend...
Saved in:
Main Authors: | Marion Ortner (Author), Marion Stange (Author), Heike Schneider (Author), Charlotte Schroeder (Author), Katharina Buerger (Author), Claudia Müller (Author), Bianca Dorn (Author), Oliver Goldhardt (Author), Janine Diehl-Schmid (Author), Hans Förstl (Author), Werner Steimer (Author), Timo Grimmer (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
by: Ortner M, et al.
Published: (2020) -
The Interplay Between Fiscal Institutions and the Great Recession: Evidence From U.S. School Districts
by: Christian Buerger, et al.
Published: (2023) -
Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
by: A. P. Pereverzev, et al.
Published: (2019) -
Intergroup Relations in Integrated Schools: A Glimpse Inside Interdistrict Magnet Schools
by: Robert Bifulco, et al.
Published: (2012) -
Parkinson's disease - a frequent cause of dementia
by: Marta Wardęszkiewicz, et al.
Published: (2024)